Y. Kawamatsu

Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic Agent

Takeshi Fujita, Yasuo Sugiyama, Shigehisa Taketomi et al. · Diabetes · 1983 · 270 citations

Diabetic Animals, Metabolic Disorder, New Antidiabetic Agent +20

Studies on antidiabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2,4-dione (ADD-3878) and its derivatives.

Takashi Sohda, Katsutoshi Mizuno, Eiko Imamiya et al. · Chemical and Pharmaceutical Bulletin · 1982 · 167 citations · Full text

Derivative (Chemistry), Medicinal Chemistry, Pharmaceutical Science +15

New 1,4-dihydropyridine derivatives with potent and long-lasting hypotensive effect.

Kanji Meguro, Masahiro Aizawa, Takashi Sohda et al. · Chemical and Pharmaceutical Bulletin · 1985 · 147 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Derivative (Chemistry) +14

Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent

T. Fujita, Yukiteru Sugiyama, Shigehisa Taketomi et al. · Diabetes · 1983 · 87 citations

Insulin Resistance, Metabolic Syndrome, Diabetes Management +11

Studies on antidiabetic agents. I. Synthesis of 5-(4-(2-methyl-2-phenylpropoxy)-benzyl)thiazolidine-2,4-dione (AL-321) and related compounds.

Takashi Sohda, Katsutoshi Mizuno, H. TAWADA et al. · Chemical and Pharmaceutical Bulletin · 1982 · 83 citations · Full text

Bioorganic Chemistry, Antidiabetic Agents, I. Synthesis +16